NKT cells and tumor immunity—a double-edged sword
- 1 December 2000
- journal article
- research article
- Published by Springer Nature in Nature Immunology
- Vol. 1 (6) , 459-460
- https://doi.org/10.1038/82698
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathwayNature Immunology, 2000
- Immune suppression and skin cancer development: regulation by NKT cellsNature Immunology, 2000
- NKT cells: facts, functions and fallaciesImmunology Today, 2000
- Interleukin (Il)-4 Is a Major Regulatory Cytokine Governing Bioactive IL-12 Production by Mouse and Human Dendritic CellsThe Journal of Experimental Medicine, 2000
- The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytesInternational Immunology, 2000
- Regulatory T CellsCell, 2000
- NKT cells are phenotypically and functionally diverseEuropean Journal of Immunology, 1999
- Simultaneous Disruption of Interleukin (IL)-4 and IL-13 Defines Individual Roles in T Helper Cell Type 2–mediated ResponsesThe Journal of Experimental Medicine, 1999
- Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cellsProceedings of the National Academy of Sciences, 1998
- IL-13, IL-4Rα, and Stat6 Are Required for the Expulsion of the Gastrointestinal Nematode Parasite Nippostrongylus brasiliensisImmunity, 1998